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Objective: Psychological states relate to changes in circulating immune cells, but associations 
with immune cells in peripheral tissues such as macrophages have hardly been investigated 
yet. Here, we aimed to implement and validate a method for measuring the microbicidal 
potential of ex vivo isolated human monocyte-derived macrophages (HMDM) as an indicator 
of macrophage activation.  
Methods: The method was implemented and validated for two blood sampling procedures 
(short-term cannula insertion vs. long-term catheter insertion) in 79 participants (34 women, 
45 men) aged between 18 and 75 yrs. The method principle is based on the reduction of 2-(4-
iodophenyl)-3-(4-nitrophenyl)-5-(2,4-dis-ulfophenyl)-2H tetrazolium, monosodium salt 
(WST-1) by superoxide anions, the first in a series of pathogen-killing reactive oxygen 
species produced by phorbol-myristate-acetate (PMA)-activated HMDM. Cytochrome c 
reduction and current generation were measured as reference methods for validation purposes. 
We further evaluated whether depressive symptom severity (Beck Depression Inventory 
[BDI]) and chronic stress (Chronic-Stress-Screening-Scale [CSSS]) were associated with 
macrophage microbicidal potential. 
Results: The assay induced superoxide anion responses by HMDM in all participants. Assay 
results depended on blood sampling procedure (cannula vs. catheter insertion). Inter-assay 
variability as a measure for assay reliability was ≤10.92%. WST-1 reduction scores correlated 
strongly with results obtained by reference methods (cytochrome c: r=.57, p=.026; current 
generation: r’s≥.47, p’s<.033) and with psychological factors (depressive symptom severity: 
r=.35 [cannula insertion] vs. r=-.54 [catheter insertion]; chronic stress: r=.36 [cannula 
insertion]; p’s<.047).  
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Conclusions: Our findings suggest that the implemented in vitro method investigates 
microbicidal potential of HMDM in a manner that is valid and sensitive to psychological 
measures. 
 
Keywords: human macrophages, microbicidal potential, reactive oxygen species, in vitro 
method, depressive mood, chronic stress 
 
Acronyms used in the text:  
ANOVA = univariate analyses of variance; BDI = Beck Depression Inventory; BMI = Body 
mass index; CSSS = Chronic-Stress-Screening-Scale; CMax = maximum current value 
registered; CSum = the sum of all current values; FBS = fetal bovine serum; HBSS = Hank’s 
balanced salt solution; HMDM = human monocyte-derived macrophages; IFN-γ = Interferon-
γ; LPS = Lipopolysaccharide; M1 macrophage = classically activated / inflammatory 
macrophage ; NADPH oxidase = nicotinamide adenine dinucleotide phosphate oxidase; OD = 
optical densitiy; PBMCs = peripheral blood nuclear cells; PBS = phosphate buffered saline; 
PMA = phorbol-myristate-acetate; ROS = reactive oxygen species; SDC = Supplemental 
Digital Content; TNF-α = tumor necrosis factor-α; WST-1 = 2-(4-iodophenyl)-3-(4-




1 Introduction  
A growing body of psychosomatic research documents that psychological states are linked to 
quantitative and qualitative alterations in circulating immune cells (e.g. (1, 2)). In contrast, 
relatively little is known about associations between psychological states and alterations in 
immune cells in peripheral tissues such as macrophages (mature, tissue-differentiated 
monocytes). Activated macrophages are important effector cells involved in warding off 
microorganisms and regulating inflammation (3). We recently found first evidence that acute 
stress relates to alterations in wound-induced macrophage activation but associations with 
longer-lasting psychological states without prior wound-induction have not yet been 
investigated (4). The lack of research in this field may be related to both the absence of and 
familiarity with methods to analyze macrophage activity. Given that macrophages are 
primarily activated to develop microbicidal effector functions (5), the purpose of our study 
was to systematically validate an in vitro method suitable for assessing microbicidal potential 
of human macrophages which may be used in future psychosomatic and psychobiological 
research. 
Microbicidal effectiveness of human macrophages is due in large part to the production of 
reactive oxygen species (ROS) (6). ROS production is mediated by activation of the 
membrane-bound enzyme complex nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase. Once activated, NADPH oxidase transfers electrons from NADPH in the cytosol to 
extracellular or intraphagolysosomal oxygen molecules. These oxygen molecules are then 
chemically reduced to superoxide anions, a type of ROS (6). The superoxide anions formed in 
this reaction serve as precursors to other, more reactive ROS such as hydrogen peroxide and 
hypochlorous acid (7). The assay presented here to study the microbicidal potential of human 
macrophages is an adaptation of a method used in a permanent monocytic cell line (THP-1 
cells) as described by Sakai et al. (8). To allow exploration of associations with psychological 
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states, we adapted the existing method to ex vivo isolated human monocyte-derived 
macrophages.  
The assay principle is based on the chemical reduction of the cell-impermeative tetrazolium 
salt WST-1 (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium 
monosodium salt) by superoxide anions that are produced by phorbol myristate acetate 
(PMA)-activated human monocyte-derived macrophages (HMDM). HMDM represent the 
classically activated (M1) macrophage also known as the inflammatory macrophage 
phenotype (9). More specifically, human blood monocytes are isolated from whole blood and 
then differentiated in vitro into inflammatory macrophages. Inflammatory macrophages are 
characterized by high cytosolic expression of NADPH oxidase, the prerequisite for high 
oxygen-dependent microbicidal activity (10). To induce macrophage microbicidal activity 
intended to destroy pathogens, NADPH oxidase needs to be activated. Activation of NADPH 
oxidase can be experimentally induced by in vitro incubation with PMA (for details see (11)). 
Once activated, the NADPH oxidase catalyzes the reduction of oxygen to superoxide anions 
which in turn reduce WST-1 (8, 12). The reduction of WST-1 results in the formation of a 
colored, water-soluble formazan salt with increased absorbance at 450 nm (8, 12). 
Consequently, the colorimetric measurement of formazan formation in the medium in which 
macrophages are suspended indicates superoxide anion-induced WST-1 reduction and thus 
macrophage (NADPH oxidase-mediated) microbicidal potential.   
In the present study, the assay implementation and validation process was as follows: First, 
we tested the influence of various stimulation agents on superoxide anion production from 
human inflammatory macrophages as well as the influence of different cell numbers on WST-
1 reduction scores in pilot studies. Second, to ensure assay reliability, we investigated the 
inter-assay variability in a sample of men and women. Additionally, to ensure validity, we 
conducted the assay and compared results with reduced cytochrome c as a reference method. 
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Next, in order to investigate sensitivity of the WST-1 macrophage assay to psychological 
states, we tested for associations of macrophage microbicidal potential with self-reported 
chronic stress and depressive symptoms severity. Notably, all blood samples for performing 
the WST-1 macrophage assay were collected by short-term cannula insertion (cannula group).  
Since we recently found first indications that the blood sampling procedure (i.e. short-term 
cannula insertion or long-term venous catheter insertion) seems to affect macrophage 
microbicidal potential (4), we additionally aimed to compare WST-1 reduction scores based 
on blood samples obtained by short-term cannula insertion with WST-1 reduction scores 
based on blood samples obtained by venous catheter inserted long enough to start wound 
healing processes (13). For this purpose, in a third sample of healthy men blood samples were 
collected via an indwelling venous catheter inserted 2 hours before the WST-1 macrophage 
assay was performed (catheter group). We additionally validated the WST-1 macrophage 
assay in the catheter group by comparing WST-1 reduction scores with current generation as a 
reference method, and tested for associations between the WST-1 macrophage assay and 
depressive symptom severity.  
 
2. Materials and methods 
2.1 Reagents and chemicals 
We used the following reagents: Ficoll-Paque PLUS (Ficoll; no. 17-1440-02; GE Healthcare; 
Uppsala, Sweden); 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium 
(WST-1; no. 150849-52-8, Dojindo Laboratories; Kumamoto, Japan); Interferon-γ (IFN-γ; no. 
PHC4031, Invitrogen; Basel, Switzerland), tumor necrosis factor-α (TNF-α; no. PHC3016, 
Invitrogen; Basel, Switzerland); Hank’s balanced salt solution without phenol red (HBSS; no. 
14025050, Invitrogen; Basel, Switzerland); fetal bovine serum (FBS; no. 10106-169, 
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Invitrogen; Basel, Switzerland); Lipopolysaccharide (LPS; no.L6529, Sigma-Aldrich; Buchs, 
Switzerland); phosphate buffered saline (PBS; no. P5368, Sigma-Aldrich; Buchs, 
Switzerland); phorbol 12-myristate 13-acetate (PMA; no. P8139, Sigma-Aldrich; Buchs, 
Switzerland); cytochrome c (no. C2037, Sigma-Aldrich; Buchs, Switzerland); RPMI-1640 
Media with Glutamax (RPMI-1640; no. W9925E, Fisher Scientifc; Wohlen, Switzerland); 
Diff-Quick (no. 130832; Siemens, Zurich, Switzerland).  
 
2.2 Participants  
The assay validation study was performed in three different samples and was conducted from 
January 2010 until March 2013.  
2.2.1 Study sample 1  
Study sample 1a consisted of 11 apparently healthy Caucasian adults (6 women, 5 men) aged 
between 23 and 34 yrs (mean age ± SEM; 27 ± 1.2 yrs) who provided one blood sample each. 
Study sample 1b consisted of four apparently healthy Caucasian women. Analogous to the 
subsequent experiments described below, we distinguished between blood sampling 
procedures: While blood samples were taken by short-term cannula insertion (cannula group) 
in study sample 1a, in study sample 1b blood samples were taken by an indwelling venous 
catheter inserted two hours before blood sampling (catheter group). The blood samples of 
study sample 1b were provided on six different days with assays run in triplicates on three 
days rendering a total of 12 measurements.  
 
 
2.2.2 Study sample 2 (cannula group) 
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The study sample consisted of 40 Caucasian adults (24 women, 16 men) aged between 18 and 
75 yrs (mean age ± SEM; 40 ± 3.1 yrs). Table 1 provides characteristics of this study sample. 
While female subjects were recruited via advertisements from the Canton of Zurich as part of 
an ongoing study on the effects of psychological stress on health outcomes, male subjects 
were recruited via advertisements from the Canton of Bern as part of an ongoing study 
assessing psychobiological mechanisms in hypertension and coronary heart disease. No 
specific exclusion criteria were applied. 
Each participant provided a blood sample taken by short-term cannula insertion and 
completed the Beck Depression Inventory (BDI) as well as the Chronic Stress Screening 
Scale (CSSS) (see below). The study protocol was formally approved by the Ethics 
Committee of the University of Zurich, Switzerland, and by the Ethics Committee of the 
Canton of Bern, Switzerland. All subjects provided written informed consent. 
 
2.2.3 Study sample 3 (catheter group)  
We recruited 24 healthy, medication-free, non-smoking Caucasian men aged between 20 and 
48 yrs (mean age ± SEM; 37 ± 1.5 yrs). Subjects’ characteristics are depicted in Table 1. 
Study participants were in good physical and mental health as confirmed by telephone 
interview. Explicit exclusion criteria were: regular strenuous exercise, smoking, alcohol and 
illicit drug abuse, any heart disease, varicosis or thrombotic diseases, elevated blood sugar 
and diabetes, elevated cholesterol, liver and renal diseases, chronic obstructive pulmonary 
disease, allergies and atopic diathesis, rheumatic diseases, and current infectious diseases. If 
the personal or medication history was not conclusive, the participants’ primary care 
physician was contacted for verification.  
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Participants were recruited via advertisements and with the help of the Swiss Red Cross of the 
canton of Zurich. Each participant provided a blood sample taken at approximately 1:30 p.m. 
by an indwelling venous catheter inserted two hours before blood sampling and completed the 
BDI (see below). Notably, we previously used this catheter-insertion procedure as an open-
wound paradigm to preactivate monocytes (4). The study protocol was formally approved by 
the Ethics Committee of the Canton of Zurich, Switzerland, and written informed consent was 
obtained from all participants. 
 
2.3 The WST-1 macrophage assay, an in vitro method for assessing macrophage NADPH 
oxidase-mediated microbicidal potential  
The method used in this study to measure macrophage superoxide anion production from ex 
vivo isolated human cells is an adaptation of a method used in a permanent monocytic cell 
line (THP-1 cells) as described by Sakai et al. (8). 
2.3.1 Monocyte isolation by adherence after Ficoll purification of peripheral blood nuclear 
cells (PBMCs) 
In order to separate the cells of interest, nine milliliters of blood were collected in EDTA-
coated tubes (Sarstedt, Numbrecht, Germany), immediately layered on top of 10 ml Ficoll 
(density-based cell separation medium) and centrifuged for 20 minutes at 300 g and 20°C. 
After centrifugation, peripheral blood nuclear cells (PBMCs, i.e. lymphocytes and 
monocytes), were removed from the interface, washed twice in RPMI1640 medium, counted 
with a hematologic analyzer (KX-21N; Sysmex Digitana AG), and re-suspended to a 
concentration of 2.5 x 106/ml with RPMI1640 media supplemented with 10% FBS. Then, 
PBMC suspension aliquots of 1 ml were transferred to 24-well cell culture plates (no. 4609; 
Semadeni; Ostermundigen, Switzerland). After incubation for 1 h at 37°C and 5% CO2, the 
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supernatant was discarded and the plate surface was rinsed five times with 1 ml of warm 
(25°C) 0.01M PBS to remove non-adherent PBMC, while monocytes remained adherent to 
the bottom of the plates. This monocyte isolation method is a well-established procedure to 
yield monocyte cultures of more than 90% purity (14-18).  
 
2.3.2 Differentiation of human monocytes into macrophages and their separation 
The resulting adherent monocyte layer (obtained as described above) was diluted with 1 ml 
RPMI1640 media supplemented with 10% FBS. Subsequently, we added 2 μl IFN-γ, 2 μl 
TNF-α, and 0.5 μl LPS resulting in a final concentration of 20 ng/ml IFN-γ, 20 ng/ml TNF-α, 
and 300 ng/ml LPS to promote differentiation of monocytes into inflammatory macrophages 
(3, 19, 20). After incubation for 48 h at 37°C and 5% CO2, the supernatant was discarded and 
the adherent macrophage layer was washed three times with 1 ml of warm (25°C) 0.01M PBS 
to remove traces of culture media and non-adherent cells.  
 
2.3.3 WST-1 assay to determine macrophage superoxide anion production  
Next, the resulting macrophage monolayer (obtained as described above) was overlaid with 1 
ml HBSS buffer solution. Subsequently, 2 μl WST-1, 0.5 μl LPS, 2 μl IFN-γ, 2 μl TNF-α, and 
0,5 μl PMA were added, resulting in a final concentration of 100 μM WST-1, 300 ng/ml LPS, 
20 ng/ml IFN-γ, 20 ng/ml TNF-α, and 50 nM PMA. This was followed by an incubation 
period of 4 hours at 37°C and 5% CO2. Then, the supernatant was removed and used to 
determine WST-1 reduction by reading the absorbance with a spectrophotometer (SmartSpec 
Plus, Bio-Rad Laboratories, Inc., Hemel Hempstead, United Kingdom for study samples 1 
and 3; Synergy HT, BioTek, Luzern, Switzerland, for study sample 2) at 450 nm against water 
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as blank. Higher optical densities (ODs) as obtained by absorbance reading are associated 
with higher amounts of WST-1 reduction and thus of superoxide anions generated by 
HMDM.  
 
2.4 Assay implementation and validation procedures  
2.4.1 Identification and verification of macrophage superoxide anion production stimulating 
agents (study sample 1) 
In order to verify the applicability of the cell-line tested in vitro method for ex vivo isolated 
HMDM, we tested the influence of different stimuli on the superoxide anion production of ex 
vivo isolated human monocytes/macrophages. Following Sakai et al (8), we used stimuli 
which initiate either cell differentiation, cell activation or both cell differentiation and 
activation. For cell differentiation, i.e. differentiation of monocytes into inflammatory 
macrophages, we used the combination of LPS, IFN-γ, and TNF-α; for cell activation, i.e. 
activation of the NADPH oxidase, we used PMA. Combined differentiation and activation 
included the use of LPS, IFN-γ, TNF-α, and PMA (detailed protocol in Section 2.3). The 
stimulation experiments were performed in the 12 subjects of study sample 1a (cannula 
group) and 12 blood samples of study sample 1b. One female subject of study sample 1a, 
however, had to be excluded due to problems with venipuncture rendering a final study 
sample of 11 (6 women, 5 men) for stimuli testing. 
 
2.4.2 Cell-number dependent WST-1 reduction (study sample 2, “cannula group”) 
In order to obtain pilot data regarding the minimum cell concentration of PBMCs needed to 
induce measurable PMA-induced superoxide anion release by HMDM we performed the 
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WST-1 macrophage assay using five different PBMC concentrations: 3.0, 2.5, 2.0, 1.5, and 
1.0 x 106 PBMCs. Experiments were carried out in cells obtained from five female subjects of 
study sample 2. 
 
2.4.3 Determination of assay reliability (study sample 2, “cannula group”) 
Assay reliability was assessed by testing inter-assay variability of blood samples split either 
before or after Ficoll purification. For details on reliability testing see Supplemental Digital 
Content (SDC) 1. Assay reliability was tested in 24 subjects of study sample 2. One female 
subject, however, had to be excluded due to technical problems rendering a final study sample 
of 23 (18 women, 5 men) for reliability testing.  
 
2.4.4 Assay validation by comparison with reference method  
2.4.4.1 Validation of the WST-1 macrophage assay by cytochrome c (study sample 2, 
“cannula group”) 
Like WST-1, cytochrome c is reduced by superoxide anions (21) and can therefore be used 
analogous to WST-1 as a detector for superoxide anion production. We thus measured the 
amount of reduced cytochrome c to validate the WST-1 macrophage assay. For details on this 
reference method see SDC 2. Assay validation using cytochrome c as reference method was 
performed in the first 15 participants of study sample 2 (11 women, 4 men). 
 
2.4.4.2 Validation of macrophage superoxide anion production by generation of electrical 
current (study sample 3, “catheter group”) 
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Current generation observed in the biofuel cell developed by Sakai et al. (8) primarily 
originates from PMA-induced superoxide anion release by THP-1-derived macrophages. The 
greater superoxide anion release, the greater current generation. Therefore, the quantity of 
electrical power produced in this biofuel cell setup represents a suitable criterion for the 
validation of the WST-1 macrophage assay. For details on this reference method see SDC 3. 
Assay validation with this reference method was carried out in 21 subjects of study sample 3. 
 
2.4.5 Macrophage number corrected WST-1 reduction (study sample 2, “cannula group”)  
Our WST-1 assay principle is based on monocytes included in 2.5 x 106 PBMC that we 
stimulate by incubation with different agents to differentiate into macrophages. Thus, possible 
differences in WST-reduction scores may relate to differences in the number of macrophages 
derived from that same number of PBMCs. Notably, the same number of PBMCs may result 
in different numbers of adherent monocyte-derived macrophages. Consequently, we aimed to 
determine the number of adherent cells per well as an indicator of the final macrophage 
number per well. We corrected WST-1 reduction score per 2.5 x 106 PBMC (i.e. total WST-1 
reduction scores) by post-hoc counted macrophage numbers to obtain a second measure of 
WST-1 reduction, i.e. macrophage number corrected WST-1 reduction score (corrected WST-
1 reduction score). For details on the cell-counting method see SDC 4. The number of 
adherent cells was determined in the first 30 participants of study sample 2 (15 women, 15 
men). 
 
2.5 Psychological assessment  
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To test for associations between microbicidal potential and psychological factors, the 
validated German versions of the following self-report questionnaires were used.   
 
2.5.1 Depressive symptom severity (study sample 2 and study sample 3) 
Depressive symptom severity was assessed with the 21-item Beck Depression Inventory 
(BDI), where scores ≥ 10 indicate possible clinical depression (22). The BDI was developed 
for the assessment of depressive symptoms that correspond to the Diagnostic and Statistical 
Manual of Mental Disorders-IV criteria for major depressive disorders and measures a 
somatic and a cognitive-affective dimension of depression (22). The BDI assesses the 
frequency and/or severity of symptoms related to sadness, feelings of guilt, perceptions of 
self-worth, suicidal ideation, and changes in appetite and body weight, among other 
characteristics. Items have a 4-point scale ranging from 0 (symptom not present) to 3 
(symptom very present). Higher scores mean higher depressive symptom severity.  
 
2.5.2 Chronic stress (study sample 2, “cannula group”) 
Chronic stress was measured using the 12-item Chronic Stress Screening Scale (CSSS) of a 
larger chronic stress questionnaire (23). The CSSS assesses the frequency of experiencing 
work overload (4 items), worries (4 items), lack of social recognition (2 item), excessive 
demands at work (1 item), and social overload (1 item). Items have a 5-point rating format 
reflecting frequency (ranging from 1 [never] to 5 [very often]). Higher scores mean higher 





2.7 Statistical analysis  
Data were analyzed using SPSS Inc. version 19.0 for Windows (Statistical Package for the 
Social Sciences, SPSS, Chicago, IL, USA) and presented as mean ± SEM. All tests were 2-
tailed with the level of significance set at p < .05. Body mass index (BMI) was calculated by 
the formula weight in kg/(height in m)2. WST-1 scores were corrected for macrophage 
numbers: “corrected WST-1 reduction” refers to WST-1 reduction scores per 10 000 
macrophages. 
Difference testing. We used univariate analyses of variance (ANOVAs) to test for differences 
(1) between cannula and catheter group (Table 1, group characteristics), (2) between men and 
women of the cannula group, (3) between the four stimulation conditions (testing of 
stimulating agents, study sample 1), and (4) between the five cell number conditions (cell-
number dependent WST-1 reduction, study sample 2).  
Reliability testing. We determined assay reliability by calculating the mean percentage 
difference between samples A1 and B (i.e. before Ficoll purification) and between samples 
A1 and A2 (i.e. after Ficoll purification).  
Validity testing. Pearson’s correlations were used to validate superoxide anion induced 
macrophage WST-1 reduction against the reference methods, i.e. cytochrome c reduction and 
superoxide anion induced macrophage current generation. Since current generation was 
monitored continuously, we extracted two indices to reflect power generation from the four-
hour recording period: first the maximum current value registered (CMax) and then the sum of 
all current values (CSum).  
Association testing. To test whether psychological factors are associated with the WST-1 
macrophage assay correlations were calculated between psychological factors (i.e. BDI and 
CSSS) and total or corrected WST-1 reduction scores adjusting for age, BMI, and gender 
16 
 
(where applicable) as a priori selected control variables because of known alterations in a 
variety of immune functions with age, BMI and gender (24-26). Unadjusted correlations are 
presented as well. 
 
3 Results  
3.1 Group characteristics (study sample 2, study sample 3) 
Table 1 provides the characteristics of study sample 2 (cannula group; n = 40) and study 
sample 3 (catheter group; n = 24). The two groups did not significantly differ in terms of age 
and BMI. The catheter group had lower BDI scores than the cannula group and subgroup 
analysis restricted to men did not change this result (6.0 ± 1.3 [cannula group] vs. 3.2 ± 0.7 
[catheter group]; p = .044). In addition, total WST-1 reduction scores were higher in the 
catheter group than in the cannula group. Within in the cannula group, men and women did 
not significantly differ in total or corrected WST-1 reduction scores (p’s > .62) independent of 
age and BMI. 
 
3.2 WST-macrophage assay implementation and validation  
3.2.1 Pilot data 
3.2.1.1 Identification and verification of macrophage superoxide anion production 
stimulating agents (study samples 1a and 1b) 
WST-1 reduction scores differed significantly between the four stimulation procedures 
(cannula group: F (3, 43) = 12.78, p < .001, n = 12 ; catheter group: F (3, 47) = 347.72, p < 
.001, n = 11; Figure 1A). Post-hoc calculated univariate ANOVAs revealed that 
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monocytes/macrophages exposed to both differentiation and activation agents showed the 
greatest WST-1 reduction capacity compared to cells treated with either none of the 
stimulation agents (cannula group: F (1, 21) = 23.7, p < .001; catheter group: F (1, 23) = 
492.54, p < .001;  negative control) or differentiation (cannula group: F (1, 21) = 16.91, p = 
.001; catheter group: F (1, 23) = 443.28, p < .001;) and activation (cannula group: F (1, 21) = 
4.95, p = .038; catheter group: F (1, 23) = 331.45, p < .001;) agents alone. 
The amount of WST-1 reduction reflects NADPH oxidase-derived superoxide anion 
production by HMDM. These results indicate that stimulation by combined cell 
differentiating and activating agents constitutes the most effective procedure for inducing 
superoxide responses.  
 
3.2.1.2 Cell-number dependent WST-1 reduction (study sample 2, “cannula group”) 
Figure 1B shows PMA-induced superoxide anion production by macrophages with WST-1 
reduction scores plotted against increasing concentrations of PBMCs. WST-1 reduction scores 
differed significantly over PBMC concentrations (F (3.7/14.9) = 37.14, p < .001, n = 5).  
 
3.2.2 Assay reliability (study sample 2, “cannula group”) 
Reliability assessment based on inter-assay variability of blood samples split before Ficoll 
purification was 9.77 % (± 6.91 SD, range = 0.00 – 21.65 %, n =23). Inter-assay variability of 






3.2.3 Assay validation by comparison with reference method  
3.2.3.1 Validation of the WST-1 macrophage assay by cytochrome c (study sample 2, 
“cannula group”) 
Higher cytochrome c reduction scores correlated significantly with higher WST-1 reduction 
scores (r = .57; p = .026; n =15; Figure 2A).  
 
3.2.3.2 Validation of macrophage superoxide anion production by generation of electrical 
current (study sample 3, “catheter group”) 
We observed current generation in HMDM of 21 participants (CMax = 0.10 ± 0.01 μA, range = 
0.05-0.24 μA; CSum = 284.12 ± 34.83 μA, range = 139.01-765.77 μA). Higher WST-1 
reduction scores correlated significantly with higher current generation (r (WST-1 reduction / 
CMax) = .48; p = .028; Figure 2B); r (WST-1 reduction / CSum ) = .47; p = .033; Figure 2C). 
Exclusion of two outlier subjects improved these positive associations (r (WST-1 reduction / 
CMax) = .50; p = .030); r (WST-1 reduction / CSum ) = .52; p = .024). 
 
3.2.4 Associations between macrophage-derived superoxide anion production and 
psychological factors   
3.2.4.1 Cannula group (study sample 2) 
In the cannula group (n = 40), both higher chronic stress (i.e. CSSS scores) and higher 
depressive symptom severity (i.e. BDI scores) correlated significantly with higher WST-
reduction scores (r (CSSS / total WST-1 reduction) = .36, p = .030; r (BDI / total WST-1 
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reduction) = .35, p = .032). Age, BMI, and gender were controlled. Additional correction of 
total WST-1 reduction scores for macrophage number per well did not change results (r (BDI 
/ corrected WST-1 reduction) = .39, p = .042, r (CSSS / corrected WST-1 reduction) = .39, p 
= .047). Without controlling for any confounders the observed association with chronic stress 
slightly increased (r (CSSS / total WST-1 reduction) = .38, p = .017) whereas the observed 
association with depressive symptom severity decreased (r (BDI / total WST-1 reduction) = 
.24, p = .14).  
 
3.2.4.2 Catheter group (study sample 3) 
In the catheter group (n = 24), higher BDI scores correlated significantly with lower total 
WST-reduction scores measured from blood sampling obtained two hours after catheter 
insertion (r (BDI / total WST-1 reduction) = -.54, p = .010). Age and BMI were controlled. 
Without controlling for covariates results become of borderline significance (r (BDI / total 
WST-1 reduction) = -.35, p = .098).  
 
4 Discussion 
In this study, we implemented and validated an in vitro method, that allows the investigation 
of NADPH oxidase-mediated microbicidal potential from ex vivo isolated HMDM.  
In a pilot study, we verified applicability of the cell-line tested in vitro method for ex vivo 
isolated HMDM. Similar to THP-1 cells and independent of the blood sampling procedure, ex 
vivo isolated human monocytes/macrophages exposed to both differentiation and activation 
agents produced the greatest amounts of superoxide anions compared to cells treated with 
either differentiating or activating stimuli alone. Application of the WST-1 macrophage assay 
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evoked significant PMA-induced superoxide anion responses by HMDM in all participants of 
study sample 2 (cannula group) and study sample 3 (catheter group). These findings indicate 
that the in vitro method described for THP-1 cells is applicable to ex vivo isolated HMDM. 
We further showed that higher depressive symptoms and higher chronic stress were 
associated with higher WST-1 reduction scores (r ≥ .35) in the cannula group. These data 
indicate that the WST-1 macrophage assay has utility for studies on effects of sustained 
psychological states on macrophage activity. Notably, the direction of these associations 
could be confirmed in men and women separately (data not shown).  
Interestingly, comparable associations with psychological factors were obtained when the 
total WST-1 reduction scores were corrected for macrophage number per well (corrected 
WST-1 reduction scores). This suggests that determination of total WST-1 reduction scores 
seems to allow for adequate assessment of microbicidal potential per macrophage. However, 
it should be kept in mind that not the total WST-1 reduction scores, but rather the corrected 
WST-1 reduction scores reflect microbicidal potential per macrophage. Also, total WST-1 
reduction scores reflect the microbicidal potential based on PBMC counts, i.e. the 
microbicidal potential of those macrophages differentiated from 2.5 x 106 PBMCs.  
In contrast to the cannula group where positive associations between WST-1 reduction and 
depressive symptom severity were found, higher depressive symptom severity was associated 
with lower levels of WST-1 reduction (r = -.54) in the catheter group. This opposite finding 
not only corroborates the data above indicating assay sensitivity to psychological factors, but 
also provides first indication that depending on the activation status of the macrophages (i.e. 
basal activity of in vivo unstimulated cells or reactive to in vivo stimulation by catheter-
induced wound-application), psychological factors can be associated in a different way with 
microbicidal potential of macrophages. Given this reasoning, the observed opposite 
association with depressive symptoms are not contradictory but rather present different 
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phenomena. Thus, basal macrophage activity might be higher with increasing depression 
scores whereas reactive macrophage activity at the same time seems to be blunted. A 
speculative explanation for the observed opposite association with depressive symptoms may 
relate to exhaustion of this inflammatory macrophage type (i.e. decreased reactivity to in vivo 
stimulation by wound-induction) due to chronically elevated basal activation. But it also 
cannot be ruled out that this observation relates to a potentially altered cell differentiation 
processes following wound-induction with depressive symptoms. 
Furthermore, in a small subsample of study sample 2 (cannula group) we investigated PBMC-
number dependent WST-1 reduction and found an increase in superoxide anion production 
with increasing PBMC concentrations in the range between 1.0 – 3.0 x 106 PBMCs. However, 
the superoxide anion production of 1.0 x 106 PBMCs was quite low suggesting that the 
minimum cell concentration of PBMCs needed to induce measureable PMA-induced 
superoxide anion release by HMDM after blood sampling by short-term cannula insertion 
ranges between 1.0 and 1.5 x 106 PBMCs. Higher PBMC cell numbers than this minimum 
concentration are therefore recommended to allow for optimal detection. In a larger 
subsample of study sample 2 (cannula group) we also tested assay reliability by using two 
different indicators of inter-assay variability. Inter-assay variabilities of the WST-1 
macrophage assay were ≤ 10.92 % suggesting that the assay is sufficiently robust for 
quantitative research. Furthermore, we evaluated the validity of the assay by comparing WST-
1 reduction scores with reference methods and found that greater WST-1 reduction was 
associated with greater cytochrome c reduction (cannula group) or current generation 
(catheter group), respectively. The observed moderate heights of the correlation coefficients 
in our study (r (WST-1 reduction / cytochrome c reduction) = .57; r (WST-1 reduction / CMax) 
= .48; r (WST-1 reduction / CSum ) = .47) suggest that the WST-1 macrophage assay provides 
a valid assessment of superoxide anion production by HMDM – especially when considering 
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that current production in the fuel cell only partially originates from superoxide anions 
produced by HMDM, while the level of WST-1 reduction is almost completely based on 
HMDM superoxide anion release.  
There are several potential implications for the implementation of the WST-1 macrophage 
assay. Thus far in the study of psychosomatic or psychobiological research, there has been a 
lack not only of methods for investigating microbicidal potential of human macrophages but 
also of literature regarding associations to longer-lasting psychological states or measures. 
However, elucidating the relationship between psychological factors and microbicidal 
potential of macrophages may contribute to a better understanding of the biological 
mechanisms linking psychological risk factors with adverse health consequences (e.g. 
increased susceptibility to infectious diseases, impaired wound healing, or coronary heart 
disease) where activated macrophages and thus peripheral immune cell activity play a major 
role (13, 27-29). Moreover, several studies have suggested altered inflammatory activity and 
disturbed neuroendocrine-immune interaction in depression. Notwithstanding the fact that the 
clinical significance of the observed association between depressive symptoms and 
macrophage activity in our study remains unclear, it might be worthwhile to further 
investigate the role of macrophage activity in the interface between inflammation, 
neuroendocrine-immune interaction, and depression. The WST-1 macrophage assay may 
facilitate future research in this field.   
Based on our implementation and validation data, we recommend the following for the use of 
the WST-1 macrophage assay: First, in order to investigate effects of potentially influencing 
factors on basal activity of M1 macrophages blood samples should be taken by means of 
short-term cannula insertion. This is because our data indicate that an indwelling venous 
catheter at least if inserted for a longer period of time) seems to function as an open wound 
and to pre-activate circulating monocytes as precursors of later M1 macrophages in vivo. 
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Second, although our data provide first indications that both total and cell-number corrected 
WST-1 reduction provide similar results in terms of associations with psychological factors 
we abstain from recommending to interpret total WST-1 reduction as an indicator of 
microbicidal potential per macrophage. Third, our data show acceptable inter-assay variability 
which suggests that single measurements of WST-1 reduction provide acceptable results. 
Nevertheless it might be methodologically stronger to perform the assay in duplicates. 
The present study has several strengths. First, it is the first study of tissue-based immune cell 
activity for use in psychosomatic research. Second, in comparison with other immunological 
methods or cell functionality assays, the in vitro method implemented in this study requires no 
expensive laboratory equipment or reagents, nor does it involve complicated procedures. 
Thus, we introduce a method that is also performable in smaller or less well equipped 
laboratories. Third, we implemented and validated the WST-1 macrophage assay for two 
commonly used blood sampling procedures, i.e. short-term cannula insertion and long-term 
catheter insertion, and in both women and men. The present study also has limitations. First, 
we did not systematically examine the association of macrophage microbicidal potential or 
ROS production with macrophage microbicidal activity. Although the important role of ROS 
in microbicidal activity of human mononuclear phagocytes is well established (6), the relative 
importance of ROS in the microbicidal activity of mononuclear phagocytes varies depending 
on the target pathogen (30-33). Future research should examine the association of macrophage 
microbicidal potential with macrophage microbicidal activity. Second, we only implemented 
the macrophage assay using WST-1 reduction as detection method for macrophage 
superoxide anion production but not using other methods for superoxide anion detection, such 
as chemiluminescence- or flow cytometry-based methods. Further studies are needed to 
address this. Third, although our study provides first indications that depressive symptom 
severity and chronic stress affect macrophage microbicidal potential, we did not examine 
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these associations systematically. Large-scale studies or studies involving depressive patients 
are needed to systematically address this (e.g. by comparing macrophage microbicidal 
potential between psychiatric patients and controls). A final limitation refers to the fact that no 
exclusion criteria were applied in the cannula group. While this procedure results in a high 
amount of generalizability on the one hand, we cannot rule out that results obtained from the 
cannula group or differential results between cannula vs. catheter group are biased by gender 
differences or potential unknown confounders on the other hand. 
In summary, we present a successful in vitro method to determine peripheral immune cell 
activity. This can be accomplished by investigation of macrophage activation using a valid 
procedure of determining the NADPH oxidase-mediated microbicidal potential of ex vivo 
isolated HMDM. The present results indicate that this method is of interest to psychosomatic 
or psychobiological research as it allows to test for associations of psychological factors with 
peripheral immune cell activity. Additional research is needed to test the effects of acute 
mental stress responses and psychological constructs other than chronic stress or depressive 
symptoms. Future studies may also elucidate the effects of different assay modulation 
procedures such as variations in concentrations of stimulating agents and how such methods 
affect the observed associations between psychological factors and immune activation. 
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Table 1. Group characteristics of participants of study sample 2 and study sample 3 
 Study sample 2 
(cannula group)  
n = 40 
Study sample 3 
(catheter group) 
n = 24 
P-value 
Gender (n; men/ 
women) 
16 / 24 24 / 0  
Age (yr) 40.2 ± 3.1 37.1 ± 1.5 .46 
BMI (kg/m2) 24.1 ± 0.6 25.8 ± 1.0 .15 
Total WST-1 (OD) 0.070 ± 0.007 0.283 ± 0.021 <.001 
Corrected WST-1 
(OD) 
0.040 ± 0.008 -  
Chronic stress (CSSS) 22.9 ± 2.0 -  
Depressive symptom 
severity (BDI)  
6.9 ± 1.1 3.2 ± 0.7 .022 
Values are means ± SEM. BMI = body mass index; OD = optical density; CSSS =  chronic 




Figure legends  
Figure 1. Pilot data. Values are given as mean ± SEM. Figure 1A depicts WST-1 reduction by 
ex vivo isolated human monocyte-derived macrophages after differential stimulation in a 
cannula and a catheter group. From the left: Non-stimulated cells as negative control; 
activation with 50 nM PMA; differentiation with 300 ng/ml LPS, 20 ng/ml IFN-γ, and 20 
ng/ml TNF-α; differentiation and activation stimuli (300 ng/ml LPS, 20 ng/ml IFN-γ, 20 
ng/ml TNF-α, 50 nM PMA). Across all measurements the combined differentiation and 
activation stimulation condition differed significantly from all of the other conditions (p’s ≤ 
.038). Figure 1B depicts PMA-induced superoxide anion production by macrophages with 
WST-1 reduction scores plotted against increasing concentrations of peripheral blood 
mononuclear cells (PBMCs). 
 
Figure 2. Validity. The scatter plot depicted in Figure 2A shows reduced cytochrome c and 
WST-1 reduction scores (cannula group). Figure 2B depicts the maximum current value 
registered (CMax) and WST-1 reduction scores (catheter group) while the sum of all current 
values (CSum) and WST-1 reduction scores (catheter group) is depicted in Figure 2C. 
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